Against the background that BCL2 and MYC are mostly co-expressed, our finding is congruent with Pillai RK et al.’s observation that unlike BCL2 DHL cases, BCL6 DHL are more likely to be CD10- but IRF4/MUM1+ and, more like Burkitt lymphoma, are cytogenetically less complex, and only infrequently express BCL2 [29], and by inference, less often express MYC. The gene discussed is BCL2; the disease is Burkitt lymphoma.